MSH2 and urothelial carcinoma: UcfDNA MSI analysis to screen for MMRd urothelial carcinoma gave encouraging results in both cohorts, with the detection of asymptomatic urothelial carcinoma in four individuals with a diagnosis of MSH2-Lynch syndrome, highlighting the potential benefit for this high-risk group.